Gary Charles Robb - May 28, 2024 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Stock symbol
CORT
Transactions as of
May 28, 2024
Transactions value $
-$298,104
Form type
4
Date filed
5/30/2024, 09:00 PM
Previous filing
Mar 5, 2024
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $36.2K +11K +54.45% $3.29 31.2K May 28, 2024 Direct F1
transaction CORT Common Stock Sale -$334K -11K -35.25% $30.39 20.2K May 28, 2024 Direct F1, F2, F3
holding CORT Common Stock 7.7K May 28, 2024 Custodial Account for Child F4
holding CORT Common Stock 8.7K May 28, 2024 Custodial Account for Child F4
holding CORT Common Stock 8.7K May 28, 2024 Custodial Account for Child F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -11K -18.02% $0.00 50K May 28, 2024 Common Stock 11K $3.29 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F2 The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.
F3 Represents the weighted average sale price for entire number of shares sold. The actual sale prices range from $29.25 to $32.00. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F4 These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
F5 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.